- Filed
- Feb 26, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Feb 18, 2026 | 115.81M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2026 | 117.9M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2026 | 117.8M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2025 | 121.4M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2025 | 121.7M sh |
| Stock Repurchased | Q2 2026 · Jan 31, 2026 | $111.2M |
| Stock Repurchased | Q2 2026 · Jan 31, 2025 | $81.6M |
| Dividends Paid | Q2 2026 · Jan 31, 2026 | $69.3M |
| Dividends Paid | Q2 2026 · Jan 31, 2025 | $64.6M |
| Capex | Q2 2026 · Jan 31, 2026 | $29.2M |
| Capex restated | Q2 2026 · Jan 31, 2025 | $44M |
| Operating Cash Flow | Q2 2026 · Jan 31, 2026 | $158.4M |
| Operating Cash Flow | Q2 2026 · Jan 31, 2025 | $163.3M |
| Short Term Debt | Q2 2026 · Jan 31, 2026 | $0 |
| Short Term Debt | Q2 2026 · Jul 31, 2025 | $31.2M |
| Cash And Equivalents | Q2 2026 · Jan 31, 2026 | $194.4M |
| Cash And Equivalents | Q2 2026 · Jul 31, 2025 | $180.4M |
| Stockholders Equity | Q2 2026 · Jan 31, 2026 | $1.58B |
| Stockholders Equity | Q2 2026 · Oct 31, 2025 | $1.52B |
| Stockholders Equity | Q2 2026 · Jul 31, 2025 | $1.45B |
| Stockholders Equity | Q2 2026 · Jan 31, 2025 | $1.54B |
| Stockholders Equity | Q2 2026 · Oct 31, 2024 | $1.54B |
| Stockholders Equity | Q2 2026 · Jul 31, 2024 | $1.49B |
| Current Liabilities | Q2 2026 · Jan 31, 2026 | $665.9M |
| Current Liabilities | Q2 2026 · Jul 31, 2025 | $757.2M |
| Total Liabilities | Q2 2026 · Jan 31, 2026 | $1.49B |
| Total Liabilities | Q2 2026 · Jul 31, 2025 | $1.52B |
| Current Assets | Q2 2026 · Jan 31, 2026 | $1.53B |
| Current Assets | Q2 2026 · Jul 31, 2025 | $1.46B |
| Total Assets | Q2 2026 · Jan 31, 2026 | $3.06B |
| Total Assets | Q2 2026 · Jul 31, 2025 | $2.98B |
| Eps Diluted | Q2 2026 · Jan 31, 2026 | $0.78 |
| Eps Diluted | Q2 2026 · Jan 31, 2026 | $1.75 |
| Eps Diluted | Q2 2026 · Jan 31, 2025 | $0.79 |
| Eps Diluted | Q2 2026 · Jan 31, 2025 | $1.60 |
| Eps Basic | Q2 2026 · Jan 31, 2026 | $0.80 |
| Eps Basic | Q2 2026 · Jan 31, 2026 | $1.78 |
| Eps Basic | Q2 2026 · Jan 31, 2025 | $0.80 |
| Eps Basic | Q2 2026 · Jan 31, 2025 | $1.63 |
| Sga Expense | Q2 2026 · Jan 31, 2026 | $162.5M |
| Sga Expense | Q2 2026 · Jan 31, 2026 | $332.1M |
| Sga Expense | Q2 2026 · Jan 31, 2025 | $159.2M |
| Sga Expense | Q2 2026 · Jan 31, 2025 | $325.3M |
| Rd Expense | Q2 2026 · Jan 31, 2026 | $18.6M |
| Rd Expense | Q2 2026 · Jan 31, 2026 | $37.8M |
| Rd Expense | Q2 2026 · Jan 31, 2025 | $21.2M |
| Rd Expense | Q2 2026 · Jan 31, 2025 | $43.9M |
| Net Income | Q2 2026 · Jan 31, 2026 | $92.5M |
| Net Income | Q2 2026 · Jan 31, 2026 | $206.4M |
| Net Income | Q2 2026 · Jan 31, 2025 | $95.9M |
| Net Income | Q2 2026 · Jan 31, 2025 | $194.9M |
| Operating Income | Q2 2026 · Jan 31, 2026 | $118.7M |
| Operating Income | Q2 2026 · Jan 31, 2026 | $268M |
| Operating Income | Q2 2026 · Jan 31, 2025 | $125.5M |
| Operating Income | Q2 2026 · Jan 31, 2025 | $256.3M |
| Gross Profit | Q2 2026 · Jan 31, 2026 | $299.8M |
| Gross Profit | Q2 2026 · Jan 31, 2026 | $628.6M |
| Gross Profit | Q2 2026 · Jan 31, 2025 | $305.9M |
| Gross Profit | Q2 2026 · Jan 31, 2025 | $625.5M |
| Cost Of Revenue | Q2 2026 · Jan 31, 2026 | $596.5M |
| Cost Of Revenue | Q2 2026 · Jan 31, 2026 | $1.2B |
| Cost Of Revenue | Q2 2026 · Jan 31, 2025 | $564.1M |
| Cost Of Revenue | Q2 2026 · Jan 31, 2025 | $1.14B |